CLVT Form 144 Notice — 100,000 Clarivate Shares to Be Sold via Morgan Stanley

Rhea-AI Filing Summary

Clarivate Plc (CLVT) submitted a Form 144 notice for a proposed sale of 100,000 common shares. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value reported as $426,370.00 and approximately 672,219,064 shares outstanding. The filer indicates these were acquired as restricted stock from the issuer on 08/13/2025 and payment was recorded the same day. An earlier sale of 100,000 common shares by the same person on 07/01/2025 generated gross proceeds of $453,000.00. The notice includes the required representation that the seller is unaware of undisclosed material adverse information.

Insights

Securities Analyst

Routine insider sale notice with limited market impact given small size relative to outstanding shares.

The Form 144 reports a proposed disposition of 100,000 Clarivate common shares through Morgan Stanley, valued at $426,370, following restricted stock acquisition on 08/13/2025. With ~672.2 million shares outstanding, this represents a de minimis fraction of the float, suggesting negligible immediate dilution or market impact. The filing follows a prior sale of 100,000 shares on 07/01/2025, indicating recent insider liquidity but not necessarily signaling material corporate developments. Disclosure conforms to Rule 144 requirements.

Corporate Governance Expert

Compliance-focused filing showing standard insider selling mechanics and required attestation.

The notice documents acquisition as restricted stock from the issuer and the intended brokered sale on NYSE, and includes the seller's attestation of no undisclosed material adverse information. Procedurally, the form meets Rule 144 disclosure elements: acquisition details, broker identity, sale timing, and prior three-month sales. From a governance standpoint, the filing is a routine transparency action rather than an indicator of management changes or governance events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	100000	426370.00	672219064	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2025	Restricted Stock	Issuer			100000	08/13/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMES SAMSON 70 St. Mary Axe London X0 EC3A 8BE	Common	07/01/2025	100000	453000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Clarivate (CLVT) report?

The Form 144 reports a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with aggregate market value $426,370.00.

When were the shares acquired that are proposed for sale?

The shares were acquired as restricted stock from the issuer on 08/13/2025, with payment recorded the same day.

Has the seller made other sales recently?

Yes. The filing discloses a prior sale of 100,000 common shares on 07/01/2025 that generated gross proceeds of $453,000.00.

Who is the broker handling the proposed sale?

The proposed sale is to be handled by Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

How large is this proposed sale relative to outstanding shares?

The filing lists 672,219,064 shares outstanding; the proposed sale of 100,000 shares is a very small fraction of that total.

Does the filer state any undisclosed material information about Clarivate?

By signing the notice, the person represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.